Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy-Breakthrough in Low-Density Lipoprotein Cholesterol Lowering, Breakdown in Value.
作者信息
Mark Daniel B, Richman Ilana, Hlatky Mark A
机构信息
Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina.
Yale University School of Medicine, New Haven, Connecticut.
出版信息
JAMA Cardiol. 2017 Oct 1;2(10):1066-1068. doi: 10.1001/jamacardio.2017.2911.
PMID:28832860
Abstract
摘要
Zotero 插件